definiens: shall mean all proprietary technical information, know - how, discoveries, improvements, processes, formulas, data ( including, without limitation, data provided by Coley to [COMPANY] under the ScreeningAgreement ), inventions ( including, without limitation, Coley Inventions and Coley Screening Inventions ( as defined inthe Screening Agreement ) ), sequences, modifications, mechanisms of action, trade secrets, instruction and otherintellectual property ( other than Coley Patent Rights ) and reagents, compositions, formulations, materials ( as well asfragments, metabolites, constituents, components, and derivatives thereof ), whether or not patentable, which relate tothe Immune Modulators and the development and use of the Products, and which are owned, proprietary to, licensedby or controlled by Coley or its Affiliates ( other than with respect to [COMPANY] Know - How licensed by Coley pursuant tothis Agreement ) as of the Effective Date or during the Term, and under which Coley or its Affiliates have the right todisclose and grant licenses . Coley Know - How shall not include discovery methods for immunomodulatory compounds, screening assays or other testing methods, trademarks, and/or copyrights